ArticleJournal of clinical medicine research2025
Effectiveness of Antibiotic Regimens in Reducing White Blood Cell Count Within Three to Five Days in Febrile Leukocytosis Treated With Ambulatory Therapy.
Article in Journal of clinical medicine research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In the absence of sepsis, patients with fever and leukocytosis in the emergency department (ED) are often treated with ambulatory parenteral antibiotics at the physician's discretion. Identifying effective regimens for reducing white blood cell (WBC) count and improving clinical outcomes may support standardized ED care. Methods: This retrospective cohort included adult ED patients with fever and leukocytosis, but without sepsis, in whom basic investigation revealed no clear source of infection. Patients received one of three regimens: (A) single-day intravenous (IV) ceftriaxone followed by oral cefixime, (B) 3-day IV ceftriaxone followed by oral cefixime, or (C) 3-day IV ceftriaxone plus oral doxycycline from day 1. Demographics, baseline data, and laboratory results were collected. Follow-up assessments included WBC count and clinical improvement. Treatment probabilities were estimated with multinomial logistic regression, and stabilized inverse probability of treatment weighting (IPTW) were applied in weighted quantile regression. Results: Among 250 patients, most were female (63.2%) with a mean age of 49 years. After adjustment, regimen C showed a median WBC reduction of -6.9 × 10 Conclusion: Though regimen C showed the steepest WBC decline and fewer failures, the study was markedly underpowered (< 10%). Larger multicenter studies are required to confirm these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.